Willner & Heller LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 536 shares of the semiconductor company's stock, valued at approximately $275,000.
A number of other hedge funds have also added to or reduced their stakes in SNPS. Nuveen LLC bought a new stake in Synopsys in the first quarter worth approximately $341,480,000. Pictet Asset Management Holding SA increased its holdings in shares of Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock valued at $1,043,518,000 after acquiring an additional 673,837 shares in the last quarter. Generation Investment Management LLP bought a new stake in shares of Synopsys during the first quarter valued at approximately $240,491,000. Vanguard Group Inc. increased its holdings in shares of Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock valued at $6,359,747,000 after acquiring an additional 346,994 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in shares of Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company's stock valued at $739,857,000 after acquiring an additional 313,218 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently commented on SNPS. Weiss Ratings restated a "hold (c)" rating on shares of Synopsys in a report on Saturday, September 27th. Citigroup downgraded Synopsys from a "neutral" rating to an "underperform" rating in a report on Wednesday, September 10th. Bank of America reiterated an "underperform" rating and set a $525.00 price target (down previously from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. KeyCorp decreased their price target on Synopsys from $660.00 to $590.00 and set an "overweight" rating for the company in a report on Wednesday, September 10th. Finally, Baird R W downgraded Synopsys from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, Synopsys currently has an average rating of "Hold" and a consensus target price of $575.31.
Read Our Latest Research Report on SNPS
Synopsys Stock Performance
NASDAQ:SNPS opened at $469.17 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The firm has a market cap of $87.15 billion, a price-to-earnings ratio of 36.83, a PEG ratio of 5.19 and a beta of 1.10. The business's fifty day moving average is $559.15 and its 200 day moving average is $509.40.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert G. Painter acquired 350 shares of the firm's stock in a transaction that occurred on Thursday, September 11th. The shares were bought at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the purchase, the director owned 2,291 shares in the company, valued at $974,683.04. This trade represents a 18.03% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is owned by company insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.